Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The group's activity appears highly profitable thanks to its outperforming net margins.

● Considering the small differences between the analysts' various estimates, the group's business visibility is good.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.

● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

● The firm trades with high earnings multiples: 27.64 times its 2024 earnings per share.

● Based on current prices, the company has particularly high valuation levels.

● The company appears highly valued given the size of its balance sheet.

● The company is highly valued given the cash flows generated by its activity.

● The company is not the most generous with respect to shareholders' compensation.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.